An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Alnylam Pharmaceuticals (Nasdaq: ALNY) will present company overviews at several virtual conferences in September 2021. Key presentation dates include the Morgan Stanley 19th Annual Global Healthcare Conference on September 9 at 3:30 PM ET, H.C. Wainwright's 23rd Annual Global Investment Conference on September 13 at 7:00 AM ET, BofA Global Healthcare Conference on September 16 at 10:05 AM ET, and Cantor Virtual Global Healthcare Conference on September 28 at 10:40 AM ET. Live webcasts will be available on the company's website, with replays accessible within 48 hours.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences being held virtually:
Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021 at 3:30 pm ET
H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021 at 7:00 am ET
BofA Global Healthcare Conference on Thursday, September 16, 2021 at 10:05 am ET
Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 10:40 am ET
A live audio webcast of each presentation will be available on the Investors section of the Company’s website at www.alnylam.com/events. A replay will be available on the Alnylam website within 48 hours after each event.
About Alnylam Alnylam (Nasdaq: ALNY) is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the potential treatment of a wide range of severe and debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam’s commercial RNAi therapeutic products are ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran), and Leqvio® (inclisiran) being developed and commercialized by Alnylam’s partner Novartis. Alnylam has a deep pipeline of investigational medicines, including six product candidates that are in late-stage development. Alnylam is executing on its “Alnylam P5x25” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA. For more information about our people, science and pipeline, please visit www.alnylam.com and engage with us on Twitter at @Alnylam, on LinkedIn, or on Instagram.
Alnylam Pharmaceuticals, Inc. Christine Regan Lindenboom (Investors and Media)
617-682-4340
Josh Brodsky (Investors)
617-551-8276
Source: Alnylam Pharmaceuticals, Inc.
FAQ
When is Alnylam Pharmaceuticals presenting at the Morgan Stanley 19th Annual Global Healthcare Conference?
Alnylam Pharmaceuticals will present on September 9, 2021, at 3:30 PM ET.
What is the schedule for Alnylam's upcoming conferences in September 2021?
Alnylam will present at multiple conferences: Morgan Stanley on September 9, H.C. Wainwright on September 13, BofA on September 16, and Cantor on September 28.
Where can I watch the Alnylam Pharmaceuticals conference presentations?
The presentations will be available via live audio webcast on Alnylam's website.
How long will the replays of Alnylam's conference presentations be available?
Replays of the presentations will be accessible within 48 hours after each event.
What is Alnylam Pharmaceuticals' focus in the biotechnology sector?
Alnylam is focused on RNA interference (RNAi) therapeutics for treating rare genetic and other diseases.
